Related Experiment Video

Updated: Apr 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K

Inflammation and poor response to treatment with erythropoietin in chronic kidney disease

Wander Valadares de Oliveira Júnior1, Adriano de Paula Sabino2, Roberta Carvalho Figueiredo1

  • 1Universidade Federal de São João Del-Rei, Brazil.

Jornal Brasileiro De Nefrologia
|July 9, 2015
PubMed

Insights

Chronic kidney disease (CKD) is rising, often linked to inflammation causing erythropoietin (EPO) resistance. This review examines EPO resistance in CKD patients with chronic inflammation.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Pathophysiology

Background:

  • Chronic kidney disease (CKD) prevalence is increasing globally.
  • Obesity, hypertension, and diabetes mellitus are key CKD risk factors.
  • Anemia is a common CKD complication, often due to iron and erythropoietin (EPO) deficiency.

Purpose of the Study:

  • To review the association between erythropoietin resistance and chronic inflammation in CKD patients.
  • To explore the impact of inflammation on EPO treatment efficacy in renal disease.

Main Methods:

  • Literature review focusing on erythropoietin resistance in CKD.
  • Analysis of studies investigating chronic inflammatory processes in renal disease patients.

Main Results:

  • Patients on dialysis often experience a chronic inflammatory state.
  • This inflammation contributes to erythropoietin resistance, worsening anemia.
  • Inflammation is linked to malnutrition, accelerated atherosclerosis, and increased mortality in CKD.

Conclusions:

  • Erythropoietin resistance in CKD is significantly associated with chronic inflammation.
  • Understanding this link is crucial for managing anemia and improving outcomes in renal disease patients.

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.9K
Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells06:23

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Published on: November 21, 2025

673

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
996
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
637
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
7.6K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
630
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.9K